Business
Paradigm (ASX:PAR) share price rises on partnership news
The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price is on the rise this morning following a partnership agreement. At the time of writing, the biopharmaceutical company’s shares are up 1.92% to $2.66.
What did Paradigm announce?
Paradigm shares are on the move today after updating the ASX with a positive announcement.
According to this morning’s release, Paradigm advised that it has entered into a collaboration agreement with bene pharmChem (Bene). This follows a recently updated exclusive licence and supply deal between both parties in September last year.
Furthermore, the new agreement will seek to co-fund new R&D projects to unlock the potential benefits of Pentosan Polysulfate Sodium (PPS). Paradigm and Bene have…
-
Business21 hours agoThe ultimate Australian stocks to buy and hold for 10+ years
-
Noosa News22 hours agoNew process turns wheat straw and oat husks into sustainable clothing
-
Noosa News17 hours agoSouthern NSW farmers call for financial relief as ongoing drought takes a toll
-
Noosa News17 hours agoLNP Premier David Crisafulli announces ‘Queensland’s royal commission’ into CFMEU